Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only
  • 12 Tips for Traveling With Diabetes
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
Latest
Popular
Top Rated
Diabetes Archives
Print | Email | Share | Comments (9)

JDRF-Funded Study Takes First Step Toward Development of Medicines That Can Regenerate Pancreases

Mar 11, 2009

Scientists are considering a two-pronged approach of having the body copy existing beta cells that are still functional while the pancreas is simultaneously induced to produce entirely new ones.

Researchers funded by the Juvenile Diabetes Research Foundation have found two chemical compounds that can trigger the growth of insulin-producing beta cells in the pancreas. The discovery could become the basis for medicines designed to regenerate the pancreas in people with type 1 diabetes.

The JDRF-sponsored team at the Genomics Institute of the Novartis Research Foundation screened a vast library of chemical compounds-more than 850,000-to see what effects they might have on triggering the production of new beta cells lines derived from mice. 

The researchers found 80 compounds that merited further investigation and eventually focused on two. One compound promotes beta cell replication by means of a biological pathway that is critical to beta cell development in embryos. The other uses an ion channel, which regulates the flow of ions across cell membranes, to induce beta cell proliferation. 

The next step will be to conduct studies on animals to see if the compounds' effects can be replicated in a whole organism. If that line of research pans out, the hope is to test the compounds on humans. 

The Novartis study continues the JDRF's focus on research into making the body re-grow beta cells that have been killed by the autoimmune effects of type 1 diabetes. They are considering a two-pronged approach of having the body copy existing beta cells that are still functional while the pancreas is simultaneously induced to produce entirely new ones.

The study was published in the Proceedings of the National Academy of Sciences


Categories: Beta Cells, Diabetes, Diabetes, Insulin, Medications Research, Professional Issues, Type 1 Issues



You May Also Be Interested In...


Click Here To View Or Post Comments

Comments 9 comments - Mar 11, 2009

©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.